vs
哈贝尔（HUBB）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
哈贝尔的季度营收约是Revvity的1.9倍（$1.5B vs $772.1M），哈贝尔净利率更高（14.6% vs 12.7%，领先1.8%），哈贝尔同比增速更快（11.9% vs 5.9%），哈贝尔自由现金流更多（$388.8M vs $161.8M），过去两年Revvity的营收复合增速更高（9.0% vs 3.3%）
哈贝尔（Hubbell Incorporated）是总部位于美国康涅狄格州谢尔顿的企业，由哈维·哈贝尔于1888年创立，1905年在康涅狄格州正式注册。公司主营电气及电子产品的设计、生产与销售，产品广泛应用于住宅、非住宅建筑、工业及公用事业等多个领域。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
HUBB vs RVTY — 直观对比
营收规模更大
HUBB
是对方的1.9倍
$772.1M
营收增速更快
HUBB
高出6.0%
5.9%
净利率更高
HUBB
高出1.8%
12.7%
自由现金流更多
HUBB
多$227.0M
$161.8M
两年增速更快
RVTY
近两年复合增速
3.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $772.1M |
| 净利润 | $217.7M | $98.4M |
| 毛利率 | 34.6% | — |
| 营业利润率 | 20.3% | 14.5% |
| 净利率 | 14.6% | 12.7% |
| 营收同比 | 11.9% | 5.9% |
| 净利润同比 | 10.5% | 3.9% |
| 每股收益（稀释后） | $4.06 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HUBBRVTY
| Q4 25 | $1.5B | $772.1M | ||
| Q3 25 | $1.5B | $698.9M | ||
| Q2 25 | $1.5B | $720.3M | ||
| Q1 25 | $1.4B | $664.8M | ||
| Q4 24 | $1.3B | $729.4M | ||
| Q3 24 | $1.4B | $684.0M | ||
| Q2 24 | $1.5B | $691.7M | ||
| Q1 24 | $1.4B | $649.9M |
净利润HUBBRVTY
| Q4 25 | $217.7M | $98.4M | ||
| Q3 25 | $255.5M | $46.7M | ||
| Q2 25 | $244.2M | $53.9M | ||
| Q1 25 | $169.7M | $42.2M | ||
| Q4 24 | $197.0M | $94.6M | ||
| Q3 24 | $219.4M | $94.4M | ||
| Q2 24 | $213.6M | $55.4M | ||
| Q1 24 | $147.8M | $26.0M |
毛利率HUBBRVTY
| Q4 25 | 34.6% | — | ||
| Q3 25 | 36.2% | 53.6% | ||
| Q2 25 | 37.2% | 54.5% | ||
| Q1 25 | 33.1% | 56.5% | ||
| Q4 24 | 33.8% | — | ||
| Q3 24 | 34.5% | 56.3% | ||
| Q2 24 | 35.0% | 55.7% | ||
| Q1 24 | 32.0% | 54.6% |
营业利润率HUBBRVTY
| Q4 25 | 20.3% | 14.5% | ||
| Q3 25 | 22.0% | 11.7% | ||
| Q2 25 | 22.7% | 12.6% | ||
| Q1 25 | 17.5% | 10.9% | ||
| Q4 24 | 19.3% | 16.3% | ||
| Q3 24 | 21.1% | 14.3% | ||
| Q2 24 | 20.7% | 12.4% | ||
| Q1 24 | 16.3% | 6.8% |
净利率HUBBRVTY
| Q4 25 | 14.6% | 12.7% | ||
| Q3 25 | 17.0% | 6.7% | ||
| Q2 25 | 16.5% | 7.5% | ||
| Q1 25 | 12.4% | 6.4% | ||
| Q4 24 | 14.8% | 13.0% | ||
| Q3 24 | 15.2% | 13.8% | ||
| Q2 24 | 14.7% | 8.0% | ||
| Q1 24 | 10.6% | 4.0% |
每股收益（稀释后）HUBBRVTY
| Q4 25 | $4.06 | $0.86 | ||
| Q3 25 | $4.77 | $0.40 | ||
| Q2 25 | $4.56 | $0.46 | ||
| Q1 25 | $3.15 | $0.35 | ||
| Q4 24 | $3.65 | $0.77 | ||
| Q3 24 | $4.05 | $0.77 | ||
| Q2 24 | $3.94 | $0.45 | ||
| Q1 24 | $2.73 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $497.9M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.8B | $7.3B |
| 总资产 | $8.2B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HUBBRVTY
| Q4 25 | $497.9M | $919.9M | ||
| Q3 25 | $680.9M | $931.4M | ||
| Q2 25 | $399.6M | $991.8M | ||
| Q1 25 | $360.3M | $1.1B | ||
| Q4 24 | $345.0M | $1.2B | ||
| Q3 24 | $445.6M | $1.2B | ||
| Q2 24 | $406.5M | $2.0B | ||
| Q1 24 | $400.3M | $1.7B |
总债务HUBBRVTY
| Q4 25 | — | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.9B | — |
股东权益HUBBRVTY
| Q4 25 | $3.8B | $7.3B | ||
| Q3 25 | $3.7B | $7.4B | ||
| Q2 25 | $3.5B | $7.6B | ||
| Q1 25 | $3.3B | $7.6B | ||
| Q4 24 | $3.3B | $7.7B | ||
| Q3 24 | $3.2B | $7.9B | ||
| Q2 24 | $3.1B | $7.9B | ||
| Q1 24 | $2.9B | $7.8B |
总资产HUBBRVTY
| Q4 25 | $8.2B | $12.2B | ||
| Q3 25 | $7.5B | $12.1B | ||
| Q2 25 | $7.1B | $12.4B | ||
| Q1 25 | $6.9B | $12.4B | ||
| Q4 24 | $6.7B | $12.4B | ||
| Q3 24 | $6.9B | $12.8B | ||
| Q2 24 | $6.9B | $13.4B | ||
| Q1 24 | $6.9B | $13.4B |
负债/权益比HUBBRVTY
| Q4 25 | — | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.44× | — | ||
| Q4 24 | 0.44× | — | ||
| Q3 24 | 0.51× | — | ||
| Q2 24 | 0.63× | — | ||
| Q1 24 | 0.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $447.5M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $388.8M | $161.8M |
| 自由现金流率自由现金流/营收 | 26.0% | 21.0% |
| 资本支出强度资本支出/营收 | 3.9% | 2.6% |
| 现金转化率经营现金流/净利润 | 2.06× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $874.7M | $509.4M |
8季度趋势，按日历期对齐
经营现金流HUBBRVTY
| Q4 25 | $447.5M | $182.0M | ||
| Q3 25 | $284.3M | $138.5M | ||
| Q2 25 | $260.6M | $134.3M | ||
| Q1 25 | $37.4M | $128.2M | ||
| Q4 24 | $432.4M | $174.2M | ||
| Q3 24 | $227.0M | $147.9M | ||
| Q2 24 | $239.6M | $158.6M | ||
| Q1 24 | $92.2M | $147.6M |
自由现金流HUBBRVTY
| Q4 25 | $388.8M | $161.8M | ||
| Q3 25 | $253.8M | $120.0M | ||
| Q2 25 | $220.7M | $115.5M | ||
| Q1 25 | $11.4M | $112.2M | ||
| Q4 24 | $364.4M | $149.8M | ||
| Q3 24 | $188.8M | $125.6M | ||
| Q2 24 | $205.7M | $136.6M | ||
| Q1 24 | $51.9M | $129.7M |
自由现金流率HUBBRVTY
| Q4 25 | 26.0% | 21.0% | ||
| Q3 25 | 16.9% | 17.2% | ||
| Q2 25 | 14.9% | 16.0% | ||
| Q1 25 | 0.8% | 16.9% | ||
| Q4 24 | 27.3% | 20.5% | ||
| Q3 24 | 13.1% | 18.4% | ||
| Q2 24 | 14.2% | 19.7% | ||
| Q1 24 | 3.7% | 20.0% |
资本支出强度HUBBRVTY
| Q4 25 | 3.9% | 2.6% | ||
| Q3 25 | 2.0% | 2.6% | ||
| Q2 25 | 2.7% | 2.6% | ||
| Q1 25 | 1.9% | 2.4% | ||
| Q4 24 | 5.1% | 3.4% | ||
| Q3 24 | 2.6% | 3.3% | ||
| Q2 24 | 2.3% | 3.2% | ||
| Q1 24 | 2.9% | 2.7% |
现金转化率HUBBRVTY
| Q4 25 | 2.06× | 1.85× | ||
| Q3 25 | 1.11× | 2.97× | ||
| Q2 25 | 1.07× | 2.49× | ||
| Q1 25 | 0.22× | 3.03× | ||
| Q4 24 | 2.19× | 1.84× | ||
| Q3 24 | 1.03× | 1.57× | ||
| Q2 24 | 1.12× | 2.87× | ||
| Q1 24 | 0.62× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HUBB
| Grid Infrastructure | $717.0M | 48% |
| Industrial | $393.7M | 26% |
| Grid Automation | $218.9M | 15% |
| Electrical Products | $163.1M | 11% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
